OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phytotherapeutic agents for neurodegenerative disorders: A neuropharmacological review
Andleeb Khan, Sadaf Jahan, Saeed Alshahrani, et al.
Elsevier eBooks (2021), pp. 581-620
Closed Access | Times Cited: 14

Showing 14 citing articles:

Citrus limon L. (lemon) seed extract shows neuro-modulatory activity in an in vivo thiopental-sodium sleep model by reducing the sleep onset and enhancing the sleep duration
Md. Mominur Rahman, Fahadul Islam, Anwar Parvez, et al.
Journal of Integrative Neuroscience (2022) Vol. 21, Iss. 1
Open Access | Times Cited: 68

Inflammation and Alzheimer’s Disease: Mechanisms and Therapeutic Implications by Natural Products
Mashoque Ahmad Rather, Andleeb Khan, Saeed Alshahrani, et al.
Mediators of Inflammation (2021) Vol. 2021, pp. 1-21
Open Access | Times Cited: 64

Neuropharmacological and Antidiabetic Potential of Lannea coromandelica (Houtt.) Merr. Leaves Extract: An Experimental Analysis
Fahadul Islam, Saikat Mitra, Mohamed H. Nafady, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-10
Open Access | Times Cited: 58

Pathogenesis of Huntington’s Disease: An Emphasis on Molecular Pathways and Prevention by Natural Remedies
Zainab Irfan, Sofia Khanam, Varnita Karmakar, et al.
Brain Sciences (2022) Vol. 12, Iss. 10, pp. 1389-1389
Open Access | Times Cited: 37

Flavonoids and Alzheimer’s disease: reviewing the evidence for neuroprotective potential
Md. Al Amin, Zerrouki Dehbia, Mohamed H. Nafady, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 6

Lipid engineered nanomaterials: A novel paradigm shift for combating stroke
Etikala Amulya, D. Bahuguna, M.P.S. Negi, et al.
Applied Materials Today (2024) Vol. 38, pp. 102194-102194
Closed Access | Times Cited: 3

Medicinal Plants and Biogenic Metal Oxide Nanoparticles: A Paradigm Shift to Treat Alzheimer’s Disease
Roby Gul, Hasnain Jan, Gul Lalay, et al.
Coatings (2021) Vol. 11, Iss. 6, pp. 717-717
Open Access | Times Cited: 21

Phytochemicals-based Therapeutics against Alzheimer's Disease: An Update
Muhammad Ayaz, Asif Nawaz, Falak Naz, et al.
Current Topics in Medicinal Chemistry (2022) Vol. 22, Iss. 22, pp. 1811-1820
Closed Access | Times Cited: 15

Protective Effect of Arzanol against H2O2-Induced Oxidative Stress Damage in Differentiated and Undifferentiated SH-SY5Y Cells
Franca Piras, Valeria Sogos, Federica Pollastro, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 13, pp. 7386-7386
Open Access | Times Cited: 2

Review on nutraceuticals: phase transition from preventive to protective care
Nishakumari Jain, Arun Radhakrishnan, Gowthamarajan Kuppusamy
Journal of Complementary and Integrative Medicine (2022) Vol. 19, Iss. 3, pp. 553-570
Closed Access | Times Cited: 12

Phytoconstituents-based nanoformulations for neurodegenerative disorders
Mithun Singh Rajput, Nilesh Prakash Nirmal, Viral Patel, et al.
Elsevier eBooks (2023), pp. 463-482
Closed Access | Times Cited: 2

Plants with Potential Neuropharmacological Activity: Plant-based Medicine for the Brain
Nripen Khare, Harshal Tare
International Journal of Pharmaceutical Quality Assurance (2024) Vol. 15, Iss. 01, pp. 523-530
Open Access

Phytovesicular Nanoconstructs For Advanced Delivery of Medicinal Metabolites: An In-Depth Review
Vishal Pandey, Sunny Rathee, D. Sen, et al.
Current Drug Targets (2024) Vol. 25, Iss. 13, pp. 847-865
Closed Access

Page 1

Scroll to top